About us
Transforming the Way We Address Barriers to Treatment
TriSalus Life Sciences® seeks to become the leader in locoregional therapeutic delivery, transforming outcomes for patients with our innovative delivery technology.
Disruptive drug delivery technology
TriSalus Life Sciences was founded with the goal of fundamentally changing cancer therapy. Our proprietary Pressure-Enabled Drug Delivery™ (PEDD™) approach, which has been used in over 24,000 procedures, improves therapy penetration in solid tumors by modulating pressure and flow to overcome the intravascular barriers to therapy delivery.
View our clinical data for SmartValve® Technology.